2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task…

By Neil J. Stone, Jennifer Robinson, Alice H. Lichtenstein, C. Noel, B. Merz, D. Lloyd-Jones, Conrad B. Blum, P. Mcbride, R. H. Eckel, F. J. S. Schwartz and 42 more. Circulation, 2014

1,670 citations recorded by the source corpus.

Preamble and Transition to ACC/AHA Guidelines to Reduce Cardiovascular Risk S2 The goals of the …

Subfields: Economics and Econometrics, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/4f741f9603a48ac975c21c23648a7e451abf42d8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Z. Younossi
2. M. Rinella
3. K. Cusi
4. A. Sanyal
5. R. Loomba

Citations in the corpus

• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases (2018, background): “Thus, it is reasonable to incorporate lipid-lowering therapy in patients with NAFLD who meet criteria based on current recommendations.((226)) Whereas reluctance to use statins in patients with suspected or established CLD, including NAFLD and NASH, may persist, several studies have established the ”